Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
194.60B
Market cap194.60B
Price-Earnings ratio
10.51
Price-Earnings ratio10.51
Dividend yield
2.86%
Dividend yield2.86%
Average volume
9.09M
Average volume9.09M
High today
$43.61
High today$43.61
Low today
$42.72
Low today$42.72
Open price
$43.21
Open price$43.21
Volume
11.03M
Volume11.03M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

The Wall Street Journal 1h
Novo Nordisk to Rebrand as Novo

Novo will be used on a day-to-day basis, while Novo Nordisk A/S will remain it's legal global company name. Tom Little / Reuters Wegovy maker Novo Nordisk NOVO...

Novo Nordisk to Rebrand as Novo
Nasdaq 2h
Novo Nordisk Unveils 'Novo' Name And 'The Novo Way' Culture

(RTTNews) - Novo Nordisk A/S (NVO, NOVO-B.CO), a healthcare company, on Monday announced a rebrand centred on "Lasting Health Starts Now" and the use of "Novo"...

Novo Nordisk Unveils 'Novo' Name And 'The Novo Way' Culture
Nasdaq 12h
Novo Nordisk May Be Poised to Outpace Eli Lilly With This Key Catalyst

Key Points Novo Nordisk launched its Wegovy pill in early 2026, with Eli Lilly quickly following with a pill called Foundayo. Novo Nordisk's pill has been ver...

Novo Nordisk May Be Poised to Outpace Eli Lilly With This Key Catalyst

More NVO News

Simply Wall St 1d
Novo Nordisk Stock Looks Like A Bargain At Current Prices - simplywall.st

...

Novo Nordisk Stock Looks Like A Bargain At Current Prices - simplywall.st
TipRanks 2d
Novo Nordisk Stock Slides as GLP-1 Fears Mount

Novo Nordisk ( (NVO) ) has fallen by -7.58%. Read on to learn why. Novo Nordisk shares fell 7.58% over the past week as investor sentiment weakened on a mix of...

Nasdaq 3d
Could This New Opportunity Be Worth Billions for Novo Nordisk?

Key Points A recent clinical trial win could help Novo Nordisk expand its GLP-1 addressable market. The company is looking to bounce back after multiple setba...

Could This New Opportunity Be Worth Billions for Novo Nordisk?
TipRanks 3d
Novo Nordisk Stock Falls After Morgan Stanley’s Sell Call on Market Share Loss to Eli Lilly, Patent Cliff

Novo Nordisk shares (NVO) fell by 2% to about $43 early Friday after Morgan Stanley analyst Thibault Boutherin downgraded the Danish pharma giant from Hold to S...

TipRanks 3d
Novo Nordisk downgraded to Underweight from Equal Weight at Morgan Stanley

Morgan Stanley downgraded Novo Nordisk (NVO) to Underweight from Equal Weight with an unchanged price target of $40. The firm cites concerns over the company’s...

Nasdaq 4d
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?

Key Points AbbVie is successfully transitioning its revenue base toward newer immunology drugs to offset the loss of patent protection for Humira. Novo Nordis...

AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
TipRanks 4d
Novo Nordisk’s Heart Failure Trial Setback: What NVO Investors Should Watch Next

Novo Nordisk (NVO) announced an update on their ongoing clinical study. The study “Effects of Ziltivekimab Versus Placebo on Morbidity and Mortality in Patient...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.